Study design and demographic parameters of respondents
| Authors and year | Study design | Control group | Sample description | Gender | Mean age (years) | Body mass index (kg/m²) | Graft source | Time since surgery (months) |
| Baez et al43 | Modified cross-sectional | No | 40 individuals with a history of unilateral ACLR | Male=15; Female=25 | 24.3±4.2 | 25.3±2.8 | NA | 68.4±15.6 |
| Barchek et al44 | Modified cross-sectional | No | 19 respondents with unilateral ACLR | Male=6; Female=13 | 22.9±3.2 | 24.3±4.5 | NA | 63.6±13.7 |
| Bell et al35 | Cross-sectional | Yes | 33 individuals with a history of primary unilateral or bilateral ACLR and 33 healthy controls | ACLR group: Male=11; Female=22 CG: Male=11; Female=22 | ACLR group: 20.3±1.8 CG: 20.8±1.6 | ACLR group: 23.7±3.2 CG: 23.3±3.0 | BTB, hamstring autograft, and allograft | 27.8±17.5 |
| Davis-Wilson et al45 | Cross-sectional | No | 66 participants that were subjected to primary ACLR | Male=36; Female=30 | 22.1±4.5 | 24.2±2.9 | BTB, semitendinosus autograft, quadriceps autograft, and allograft | 28.1±33.4 |
| Ezzat et al36 | Cohort | Yes | 51 athletes with primary unilateral ACLR and their 51 healthy peers | Female | ACLR group: 18.3±2.2 CG: 18.1±2.0 | ACLR group: 23.3±3.9 CG: 22.6±2.5 | NA | 13.2±14.6 |
| Kuenze et al37 | Observational | Yes | 31 respondents that underwent primary unilateral or bilateral ACLR and 31 participants without a history of ACLR | ACLR group: Male=8; Female=23 CG: Male=8; Female=23 | ACLR group: 19.8±1.4 CG: 20.6±1.7 | ACLR group: 23.7±3.0 CG: 23.2±3.0 | BTB and hamstring autograft | 26.8±15.8 |
| Kuenze et al38 | Cross-sectional | Yes | 59 individuals with primary unilateral or bilateral ACLR and 55 healthy control respondents | ACLR group: Male=25; Female=34 CG: Male=22; Female=33 | ACLR group: 20.5±2.4 CG: 20.5±1.8 | ACLR group: 24.2±2.9 CG: 23.9±2.9 | BTB, hamstring autograft, and allograft | 29.0±17.3 |
| Kuenze et al46 | Cross-sectional | No | 23 adults that underwent primary unilateral ACLR | Male=9; Female=14 | 22.5±5.0 | 26.6±4.1 | BTB, hamstring autograft, and allograft | 8.2±2.1 |
| Kuenze et al42 | Observational | No | 12 individuals that were subjected to primary unilateral ACLR | Male=2; Female=10 | 22.0±3.0 | 23.5±2.9 | Hamstring autograft and patellar tendon | 56.0±36.3 |
| Lisee et al39 | Cross-sectional | Yes | 57 respondents with a history of primary unilateral ACLR and their 42 non-injured counterparts | ACLR group: Male=23; Female=34 CG: Male=20; Female=22 | ACLR group: 20.9±3.2 CG: 20.7±1.7 | ACLR group: 25.3±3.1 CG: 25.4±3.3 | NA | 28.7±17.7 |
| Toomy et al40 | Historical cohort | Yes | 25 out of 42 individuals experienced ACLR and 43 healthy controls | ACLR group: Male=18; Female=24 CG: Male=18; Female=25 | ACLR group: 23.7±2.9 CG: NA | ACLR group; 25.7±5.1 CG: NA | NA | NA |
| Triplett and Kuenze41 | Cross-sectional | Yes | 10 participants with a history of unilateral ACLR and 10 noninjured controls | Female | ACLR group: 21.4±3.8 CG: 21.9±3.1 | ACLR group: 26.1±3.8 CG: 21.8±2.5 | BTB, hamstring autograft, and quadriceps autograft | 33.0±18.3 |
Values of variables mean age (years), body mass index (kg/m²), and time since surgery (months) are expressed as mean and SD.
ACLR, anterior cruciate ligament reconstruction; BTB, bone tendon bone; CG, control group; NA, not applicable.